Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
N De Mario & Mario is an independent UK-based pharmaceutical wholesaler specializing in regulatory compliance, distribution of generics, branded drugs, specialties, OTCs, and orphan drugs. The company facilitates Named Patient Programs (NPP) and Early Access Programs (EAP), supporting global access to medicines through partnerships with manufacturers and expertise in product registration for new markets. They do not develop their own therapeutics but enable patient access to a wide range of pharmaceuticals worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on N De Mario & Mario.